Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Feb 05, 2024 | Feb 07, 2024 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $17.45 | $80,249 | -74.09% |
Jan 05, 2024 | Jan 08, 2024 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $19.16 | $88,116 | -74.09% |
Dec 05, 2023 | Dec 07, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $16.3 | $74,996 | -74.09% |
Nov 22, 2023 | Nov 27, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $15 | $207,000 | -89.56% |
Jul 05, 2023 | Jul 07, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $17.3 | $38,915 | -58.31% |
Jun 05, 2023 | Jun 07, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $16.26 | $36,576 | -58.31% |
May 05, 2023 | May 09, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $20.87 | $46,957 | -58.31% |
Apr 05, 2023 | Apr 07, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $18.2 | $40,942 | -58.31% |
Mar 06, 2023 | Mar 08, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $23.75 | $53,440 | -58.31% |
Feb 06, 2023 | Feb 08, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $24.27 | $54,612 | -58.31% |
Jan 05, 2023 | Jan 09, 2023 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $26.4 | $59,405 | -58.31% |
Dec 05, 2022 | Dec 07, 2022 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $17.38 | $39,114 | -58.31% |
Nov 07, 2022 | Nov 09, 2022 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $19.2 | $43,194 | -58.31% |
Oct 05, 2022 | Oct 07, 2022 | Niven Ralph CHIEF SCIENTIFIC OFFICER | Sell | Aerovate Therapeutics, Inc. | AVTE | $15.75 | $35,447 | -58.31% |
Sep 06, 2022 | Sep 07, 2022 | Niven Ralph Chief Scientific Officer | Sell | Aerovate Therapeutics, Inc. | AVTE | $19 | $42,750 | -58.31% |
Aug 18, 2022 | Aug 19, 2022 | Niven Ralph Chief Scientific Officer | Sell | Aerovate Therapeutics, Inc. | AVTE | $21.18 | $47,657 | -58.31% |